Future Financial Wealth Managment LLC Buys 925 Shares of UnitedHealth Group Incorporated $UNH

Future Financial Wealth Managment LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 164.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,486 shares of the healthcare conglomerate’s stock after purchasing an additional 925 shares during the quarter. Future Financial Wealth Managment LLC’s holdings in UnitedHealth Group were worth $464,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the period. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at approximately $42,000. Kentucky Trust Co raised its position in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after buying an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $360.17 on Friday. The company has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. The firm’s 50-day moving average is $307.84 and its 200 day moving average is $355.58. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Royal Bank Of Canada reduced their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Finally, UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.